Is 60 DEGREES PHARMACEUTICALS, INC. (SXTP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 5.9% / 30% | 62.9% / 30% | 18.4% / 30% | 290.9% / 5% | ✗ NOT HALAL |
| DJIM | 5.9% / 33% | 62.9% / 33% | 18.4% / 33% | 290.9% / 5% | ✗ NOT HALAL |
| MSCI | 2.7% / 33% | 28.8% / 33% | 8.5% / 33% | 290.9% / 5% | ✗ NOT HALAL |
| S&P | 5.9% / 33% | 62.9% / 33% | 18.4% / 33% | 290.9% / 5% | ✗ NOT HALAL |
| FTSE | 2.7% / 33% | 28.8% / 33% | 8.5% / 50% | 290.9% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 42.9% | |
| Operating Margin | -440.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -154.8% | |
| Return on Assets (ROA) | -70.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$6M |
| Free Cash Flow | -$6M |
| Total Debt | $155,891 |
| Debt-to-Equity | 3.5 |
| Current Ratio | 2.9 |
| Total Assets | $6M |
Price & Trading
| Last Close | $1.49 |
| 50-Day MA | $3.03 |
| 200-Day MA | $4.87 |
| Avg Volume | 4.7M |
| Beta | 3.0 |
|
52-Week Range
$1.29
| |
About 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is 60 DEGREES PHARMACEUTICALS, INC. (SXTP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), 60 DEGREES PHARMACEUTICALS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is 60 DEGREES PHARMACEUTICALS, INC.'s debt ratio?
60 DEGREES PHARMACEUTICALS, INC.'s debt ratio is 5.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.7%.
What are 60 DEGREES PHARMACEUTICALS, INC.'s key financial metrics?
60 DEGREES PHARMACEUTICALS, INC. has a market capitalization of $4M, and revenue of $607,574. Return on equity stands at -154.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.